Respiratory infections
Thoracic oncology
PG5 Postgraduate course
Pleural disease: integrating 2020 evidence with real life cases
Clinical
Aims : To present all aspects of pleural disease, including 1) the pathophysiology of effusion formation and symptoms; 2) the optimal diagnostic methods, including emerging data on rationalisation steps and direct-to-biopsy strategies; 3) a synthesis of high-quality evidence that enables management of patients with malignant pleural effusion; 4) the evolving oncological management of mesothelioma; 5) pleural infection: from bench-to-bedside; and 6) a review of the optimal management of pneumothorax, including the results of soon to be published phase III trials of ambulatory/conservative strategies.
Target audience :
Clinical researcher, General practitioner, Thoracic oncologist, Thoracic surgeon
Methods :
Endoscopy and interventional pulmonology, General respiratory patient care, Imaging
09:30
Mechanisms of effusion formation and symptoms: physiology, consequences and implications for management
S. Zarogiannis(Larisa, Greece)
COI
-
Description
1
10:00
Diagnostic pleural pathway: time for pathway rationalisation?
R. Asciak(SIGGIEWI, Malta)
COI
-
Description
2
10:30
Malignant pleural effusion: drainage, talc and beyond
K. Blyth(Glasgow (Glasgow), United Kingdom)
COI
-
Description
3
11:30
Pleural infection: are we getting it right?
N. Rahman(ABINGDON, United Kingdom)
COI
-
Description
5
12:00
Mesothelioma: emerging evidence and updated guidelines
A. Scherpereel(Lille Cedex, France)
COI
-
Description
6
12:30
Pneumothorax 2020: beyond the current guidelines
J. Janssen(Nijmegen, Netherlands)
COI
R. Hallifax(Oxford (Oxfordshire), United Kingdom)
COI
-
Description
7
. . .